0001209191-16-125612.txt : 20160603 0001209191-16-125612.hdr.sgml : 20160603 20160603162024 ACCESSION NUMBER: 0001209191-16-125612 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160601 FILED AS OF DATE: 20160603 DATE AS OF CHANGE: 20160603 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: OXIGENE INC CENTRAL INDEX KEY: 0000908259 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 133679168 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 701 GATEWAY BLVD. CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 650-635-7000 MAIL ADDRESS: STREET 1: 701 GATEWAY BLVD. CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: McMahon Gerald PhD CENTRAL INDEX KEY: 0001290747 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-21990 FILM NUMBER: 161695943 MAIL ADDRESS: STREET 1: 300 ELLIOTT AVENUE WEST STREET 2: SUITE 500 CITY: SEATTLE STATE: WA ZIP: 98119-4114 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2016-06-01 0 0000908259 OXIGENE INC OXGN 0001290747 McMahon Gerald PhD C/O OXIGENE, INC. 701 GATEWAY BLVD., SUITE 210 SOUTH SAN FRANCISCO CA 94080 1 0 0 0 Stock Option (Right to Purchase) 0.65 2016-06-01 4 A 0 91564 0.00 A 2022-06-01 Common Stock 91564 91564 D Dr. McMahon was awarded options to purchase shares of OXiGENE, Inc. common stock, $0.01 par value per share (the "Stock Options"), in connection with his service as a member of the Board of Directors pursuant to the OXiGENE, Inc. 2015 Equity Incentive Plan and the Amended and Restated Non-Employee Director Compensation Policy. The Stock Options will vest in full on June 1, 2017, subject to Dr. McMahon's continued service on the Board of Director as of such date. Megan N. Gates, attorney-in-fact 2016-06-03